VESIcare Clinical Trials VESIcare RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Efficacy of Mirabegron Versus Tamsulosin Versus Solifenacin for Treatment of Ureteral Stents-Related Symptoms
Conditions:   Ureteral Stent;   Stent Related Symptoms Interventions:   Drug: Mirabegron 50 MG;   Drug: Tamsulosin;   Drug: Solifenacin Succinate 10 MG;   Drug: Placebo oral tablet Sponsor:   Mansoura University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2020 Category: Research Source Type: clinical trials